Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04118673Not ApplicableTerminated

Secondary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (S-PLAC 2)

Role: collaborator

NCT04979455Active Not Recruiting

Risk Factors for Exertional Heat Illness

Role: collaborator

NCT05880329Recruiting

DIagnoSing Care hOme UTI Study

Role: collaborator

NCT05303142Completed

Comparing Exertional Heat Illness Risk Factors Between Patients and Controls

Role: collaborator

NCT03935906Not ApplicableCompleted

Reaching mEthadone Users Attending Community pHarmacies With HCV

Role: collaborator

NCT04113213Not ApplicableSuspended

Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health

Role: collaborator

All 6 trials loaded